To boost supply of the injectable chemotherapy drug cisplatin – the US is facing a shortage of oncology treatments – the Food and Drug Administration (FDA) will...
05.03.2013
- U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...
30.05.2012
- Norway's Pronova BioPharma , which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies. The victory over...
